Confirming this, a proteomic approach allowed, among a panel of 175 different markers, the identification of six markers, including adrenomedullin, able to predict long-term outcomes in patients with renal failure and myocardial infarction [30]. This evidence concerns the gene ADM and Renal insufficiency.